See every side of every news story
Published loading...Updated

BD intent to separate business could allow competitors to rise in IVD test markets, says GlobalData - GlobalData

Summary by GlobalData
Becton Dickinson (BD) has recently announced its intent to separate its biosciences and diagnostic solutions business. The biosciences segment includes research instruments and reagents, and single-cell multiomics, while the diagnostic solutions segment consists of microbiology and infectious disease diagnostics. According to the company, the two segments earned over $3 billion in revenue in fiscal 2024. BD’s move could allow competitors to rise…
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

1 Articles

All
Left
Center
Right
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

GlobalData broke the news in on Thursday, February 20, 2025.
Sources are mostly out of (0)